Hygiene Adhesive Market Focused Insights Report 2025-2030, with Profiles of Key Vendors 3M, Arkema, Dow, H.B. Fuller, Henkel and Synthomer
The 'Hygiene Adhesive Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering.
The Hygiene Adhesive Market was valued at USD 2.53 billion in 2024, and is projected to reach USD 3.64 billion by 2030, rising at a CAGR of 6.25%.
The market is growing strongly due to the growing demand for hygiene products. Additionally, population growth, urbanization, and awareness about hygiene have contributed to the huge demand for good-quality, skin-friendly, and long-lasting hygiene products.
Governments and health organizations are also contributing significantly to market growth. For example, the Indian government's 'Swachh Bharat Abhiyan' (Clean India Mission) encourages hygiene awareness, which has resulted in higher demand for disposable sanitary products. Likewise, the United Nations and other non-governmental organizations (NGOs) are working diligently to enhance menstrual hygiene awareness, driving sales of feminine hygiene products.
KEY TAKEAWAYS
Global Hygiene Adhesives Market Trends & OpportunitiesSustainable & Bio-Based Adhesives
The market is experiencing a shift towards sustainable and bio-based adhesives, spurred by environmental regulations and consumer demand for eco-friendly products. Companies are developing biodegradable, water-based, and plant-derived adhesives. Bostik's hot-melt polyamide adhesives, made from 80% fatty acids, exemplify this trend.
Smart Hygiene Products
Smart hygiene adhesives enhance comfort, absorbency, and skin-friendliness, minimizing irritation risks. They improve the performance of absorbent products like baby diapers and adult incontinence products. The integration of conductive inks is innovating these adhesives, helping caregivers easily detect when diapers need changing.
Global Hygiene Adhesives Market DriversRise of E-Commerce
The growth of e-commerce is boosting the market by offering convenience, competitive prices, and diverse product availability. Subscription models and bulk purchases enhance sales volumes, necessitating robust adhesive supply for product manufacturing.
Growth in Personal Hygiene Awareness
Campaigns by WHO and UNICEF promote hygiene awareness, increasing demand for sanitary products that use high-quality adhesives. Greater awareness of infant hygiene also fuels demand for superior diapers, further driving innovation in adhesive technology.
Industry RestraintsVolatility in Raw Material Prices
The market faces challenges from fluctuating prices of petroleum-based raw materials, impacting production costs and deterring investment in R&D and innovation.
GLOBAL HYGIENE ADHESIVES MARKET GEOGRAPHICAL ANALYSIS
The APAC region accounts for the largest global hygiene adhesives market share of over 35% and shows the highest growth during the forecast period. The market is driven by a combination of robust economic growth, improved consumer awareness, and advancement in manufacturing and technology.
Within the personal care segment, rising disposable incomes and emerging middle classes in countries like China and India are fueling demand for premium hygiene products such as baby diapers, feminine hygiene, and adult incontinence. Increasing urbanization and improved lifestyles have led consumers to prioritize comfort and safety, generating a demand for improved adhesive technologies that provide secure fastening, skin-friendliness, and better breathability.
The medical and healthcare industry in APAC is also experiencing fast growth, fueled by an aging population and a growing incidence of chronic diseases. This has boosted demand for advanced wound care products, surgical tapes, transdermal patches, etc. Japan and South Korea are leading the way in medical innovation, creating adhesives with better biocompatibility, antimicrobial activity, and performance in moist conditions.
GLOBAL HYGIENE ADHESIVES MARKET VENDOR LANDSCAPE
The global hygiene adhesive market consists of exclusive data on 20 vendors. The market has many players. Major vendors compete aggressively to strengthen their position, while smaller players try to capture niche markets by offering cost-effective or specialized solutions. International players are expanding aggressively, making it increasingly difficult for regional vendors to compete. Larger companies leverage strong distribution networks, advanced R&D, and brand reputation to maintain dominance.
The future of hygiene adhesives relies on innovative product features, such as sustainable adhesives, better adhesion performance, and improved application methods. The shift toward sustainability is driving bio-based and solvent-free adhesives.
The hygiene adhesives market is susceptible to counterfeit and low-quality products, which can disrupt pricing and reduce consumer trust in adhesive-based hygiene products.
Top Companies in Global Hygiene Adhesives Market
Other Prominent Vendors
Key Attributes:
MARKET SEGMENTATION & FORECASTS
For more information about this report visit https://www.researchandmarkets.com/r/d0roll
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250519422326/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected] E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: OTHER MANUFACTURING MANUFACTURING
SOURCE: Research and Markets
Copyright Business Wire 2025.
PUB: 05/19/2025 06:55 AM/DISC: 05/19/2025 06:54 AM
http://www.businesswire.com/news/home/20250519422326/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
107% earnings growth over 1 year has not materialized into gains for Genuit Group (LON:GEN) shareholders over that period
Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. For example, the Genuit Group plc (LON:GEN) share price is down 21% in the last year. That falls noticeably short of the market return of around 23%. At least the damage isn't so bad if you look at the last three years, since the stock is down 7.7% in that time. The falls have accelerated recently, with the share price down 13% in the last three months. This could be related to the recent financial results - you can catch up on the most recent data by reading our company report. If the past week is anything to go by, investor sentiment for Genuit Group isn't positive, so let's see if there's a mismatch between fundamentals and the share price. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the unfortunate twelve months during which the Genuit Group share price fell, it actually saw its earnings per share (EPS) improve by 107%. It's quite possible that growth expectations may have been unreasonable in the past. The divergence between the EPS and the share price is quite notable, during the year. So it's easy to justify a look at some other metrics. Genuit Group's revenue is actually up 5.9% over the last year. Since the fundamental metrics don't readily explain the share price drop, there might be an opportunity if the market has overreacted. You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values). We know that Genuit Group has improved its bottom line lately, but what does the future have in store? This free report showing analyst forecasts should help you form a view on Genuit Group What About Dividends? As well as measuring the share price return, investors should also consider the total shareholder return (TSR). Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Genuit Group the TSR over the last 1 year was -18%, which is better than the share price return mentioned above. This is largely a result of its dividend payments! A Different Perspective While the broader market gained around 23% in the last year, Genuit Group shareholders lost 18% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 0.6% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For instance, we've identified 1 warning sign for Genuit Group that you should be aware of. But note: Genuit Group may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Fletcher King Full Year 2025 Earnings: EPS: UK£1.48 (vs UK£0.028 in FY 2024)
Explore Fletcher King's Fair Values from the Community and select yours Fletcher King (LON:FLK) Full Year 2025 Results Key Financial Results Revenue: UK£3.84m (flat on FY 2024). Net income: UK£153.0k (down 46% from FY 2024). Profit margin: 4.0% (down from 7.4% in FY 2024). EPS: UK£1.48. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Fletcher King shares are up 5.6% from a week ago. Risk Analysis We don't want to rain on the parade too much, but we did also find 3 warning signs for Fletcher King (1 is a bit unpleasant!) that you need to be mindful of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
Mutares SE KGaA Reports Second Quarter 2025 Earnings
Explore Mutares SE KGaA's Fair Values from the Community and select yours Mutares SE KGaA (ETR:MUX) Second Quarter 2025 Results Key Financial Results Revenue: €2.38b (up 83% from 2Q 2024). Net income: €40.8m (up from €101.2m loss in 2Q 2024). Profit margin: 1.7% (up from net loss in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Mutares SE KGaA Earnings Insights Looking ahead, revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 1.3% growth forecast for the Capital Markets industry in Germany. Performance of the German Capital Markets industry. The company's share price is broadly unchanged from a week ago. Risk Analysis It is worth noting though that we have found 3 warning signs for Mutares SE KGaA that you need to take into consideration. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
